Jon Cuthbert

Aristocrat Leisure (ASX:ALL) and Light & Wonder (ASX:LNW) have reached a settlement resolving litigation in Australia and the United States over Light & Wonder’s Dragon Train and Jewel of the Dragon games.

UBS has forecast that silver could continue its strong upward trend into 2026 after posting one of its best performances among major commodities in 2025.

Bank of New York Mellon has launched a tokenised deposit service that allows institutional clients to convert cash balances into digital tokens.

Palvella Therapeutics (NASDAQ:PVLA) issued a comprehensive 2026 corporate update detailing significant progress across its late-stage QTORIN platform, which leverages a proprietary topical rapamycin formulation for the treatment of rare dermatological and vascular conditions.

Polestar Automotive Holding UK (NASDAQ:PSNY) reported its strongest sales year to date on Friday, defying a broader slowdown in the electric vehicle sector with a 34% surge in annual retail deliveries.

Liquidia Corporation (NASDAQ:LQDA) reported preliminary, unaudited commercial performance metrics for its lead product YUTREPIA (treprostinil) inhalation powder for the fourth quarter and full year ended December 31, 2025.

Kezar Life Sciences (NASDAQ:KZR) announced Friday that the FDA has granted a formal Type C meeting for the first quarter of 2026, a move that could revive the clinical path for its lead asset, zetomipzomib, following months of regulatory uncertainty.

Appian Corp. (NASDAQ:APPN) announced it will pursue a second trial in its long-running trade secrets battle against Pegasystems (NASDAQ:PEGA0, following a Virginia Supreme Court ruling that refused to dismiss the case but sent it back to a lower court for a fresh look.

Zelensky says Ukraine has yet to receive firm security guarantees from allies amid ongoing peace discussions with Russia.

Optimism is considering funding OP token buybacks with Superchain fees to better align the asset’s value with network growth.